Sarcopenia is a major driver of disability, frailty, and loss of independence in ageing populations. Current consensus definitions have shifted from low muscle mass to low muscle strength and impaired physical performance as the defining clinical features. The underlying disease model, however, has remained predominant...
L. B. R. Orssatto, W. D. Arnold, L. Ferrucci et al.· The Lancet Healthy Longevity· 1 citation
ABSTRACT Age‐related weakness is strongly associated with disability and mortality in older adults. While muscle atrophy contributes to weakness, strength declines at a faster rate than muscle mass, implicating neural mechanisms such as changes at the spinal cord and neuromuscular junction. Yet, the role of the motor c...
Jose A. Viteri, Nathan R. Kerr, Fereshteh B. Darvishi et al.· Aging Cell· 0 citations
CRISPR-SWITCH is presented, a genome engineering strategy that enables deliberate monoallelic editing by exploiting allele-specific CRISPR targeting and can enforce heterozygosity at endogenous loci and enable the generation of viable mammalian models for dominant-negative and dosage-sensitive genetic disorders.
Samantha Norris, Sai Goutham Reddy Yeddula, E. Su et al.· Frontiers in Genome Editing· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.